Beta Bionics Inc Revenue Growth Rates (BBNX), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Beta Bionics Inc   (NASDAQ: BBNX)
 

BBNX's Revenue Growth by Quarter and Year

Beta Bionics Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BBNX Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 32.01
1st Quarter March 27.44
FY 59.45





BBNX Revenue second quarter 2026 Y/Y Growth Comment
Beta Bionics Inc achieved in the second quarter 2026, above Company average Revenue rise of 42.28% year on year, to $ 32.01 millions.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 88 other companies have achieved higher Revenue growth. While Beta Bionics Inc ' s Revenue jump of 42.28% ranks overall at the positon no. 1339 in the second quarter 2026.


BBNX Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 61.15 % - -
3rd Quarter September - 62.3 % - -
2nd Quarter June 42.28 % 49.5 % - -
1st Quarter March 61.7 % 31.25 % - -
FY   - 52.82 % - -

Financial Statements
Beta Bionics Inc 's second quarter 2026 Revenue $ 32.01 millions BBNX's Income Statement
Beta Bionics Inc 's second quarter 2025 Revenue $ 22.50 millions Quarterly BBNX's Income Statement


BBNX Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 21.46 % 22.32 % -
3rd Quarter September - 20.53 % 11.03 % -
2nd Quarter June 16.67 % 32.59 % 16.4 % -
1st Quarter March -16.7 % -16.98 % - -
FY (Year on Year)   - 52.82 % - -


Back to BBNX Growth rate Comparisons >> Back to BBNX Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #89
Healthcare Sector #236
Overall #1339

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #89
Healthcare Sector #236
Overall #1339
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Beta Bionics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
32.6 % 0.24 % -100 %
(Jun 30 2025)  


BBNX's II. Quarter Q/Q Revenue Comment
Beta Bionics Inc achieved in the II. Quarter 2026 above company average sequential Revenue jump of 16.67%, to $ 32.01 millions, from $27.44 millions in the first quarter.

Within Medical Equipment & Supplies industry 27 other companies have achieved higher Revenue quarter on quarter growth. While Beta Bionics Inc 's Revenue growth quarter on quarter, overall rank is 598.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #28
Healthcare Sector #109
Overall #598
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #28
Healthcare Sector #109
Overall #598
Revenue Q/Q Growth Statistics
High Average Low
32.6 % 0.24 % -100 %
(Jun 30 2025)  


BBNX's II. Quarter Q/Q Revenue Comment
Beta Bionics Inc achieved in the II. Quarter 2026 above company average sequential Revenue jump of 16.67%, to $ 32.01 millions, from $27.44 millions in the first quarter.

Within Medical Equipment & Supplies industry 27 other companies have achieved higher Revenue quarter on quarter growth. While Beta Bionics Inc 's Revenue growth quarter on quarter, overall rank is 598.


Beta Bionics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 119.51 $ 110.00 $ 99.54 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) 55.98 % 59.05 % 52.84 % - -
Year on Year Revenue Growth Overall Ranking # 315 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 8.65 % 10.51 % 14.37 % - -
Seq. Revenue Growth (TTM) Overall Ranking # 1339 # 1237 # 0 # 0 # 0


Cumulative Revenue growth Comment
Assuming the Beta Bionics Inc 's fiscal year would have ended in Jun 30 2026, Beta Bionics Inc would have reprted above average annual Revenue growth of 55.98% year on year, of $ 120 millions.
This marks a slow-down of the companys growth trends and from the 59.05% increase in Mar 31 2026.

In the Healthcare sector 86 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 315.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 89
Healthcare Sector # 87
Overall # 315

Revenue TTM Y/Y Growth Statistics
High Average Low
59.05 %
 55.96 %
52.84 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 89
Sector # 236
S&P 500 # 1339
Cumulative Revenue growth Comment
Assuming the Beta Bionics Inc 's fiscal year would have ended in Jun 30 2026, Beta Bionics Inc would have reprted above average annual Revenue growth of 55.98% year on year, of $ 120 millions.
This marks a slow-down of the companys growth trends and from the 59.05% increase in Mar 31 2026.

In the Healthcare sector 86 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 315.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 89
Healthcare Sector # 87
Overall # 315

Revenue TTM Y/Y Growth Statistics
High Average Low
59.05 %
55.96 %
52.84 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 89
Sector # 236
S&P 500 # 1339




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BBNX's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Madrigal Pharmaceuticals Inc 71.17%$ 71.169 millions
Tg Therapeutics Inc 70.27%$ 70.272 millions
Tarsus Pharmaceuticals Inc 69.41%$ 69.406 millions
Hyperfine Inc 67.70%$ 67.698 millions
Alnylam Pharmaceuticals Inc 66.86%$ 66.856 millions
Emergent Biosolutions Inc 66.29%$ 66.288 millions
Vivos Therapeutics Inc 65.69%$ 65.691 millions
Iovance Biotherapeutics inc 65.65%$ 65.654 millions
Billiontoone Inc 64.40%$ 64.403 millions
Anteris Technologies Global Corp 63.27%$ 63.269 millions
Nexgel Inc 63.24%$ 63.242 millions
Carlsmed Inc 59.58%$ 59.575 millions
Sonoma Pharmaceuticals Inc 59.55%$ 59.552 millions
Arcutis Biotherapeutics Inc 59.33%$ 59.331 millions
Nephros Inc 58.55%$ 58.551 millions
Bioadaptives Inc 54.95%$ 54.955 millions
Zevra Therapeutics Inc 53.25%$ 53.251 millions
Beyond Air Inc 52.94%$ 52.941 millions
Caredx Inc 52.23%$ 52.226 millions
Bioxcel Therapeutics Inc 51.67%$ 51.667 millions
Glaukos Corp50.63%$ 50.628 millions
Heartflow Inc 49.80%$ 49.801 millions
Coya Therapeutics Inc 48.97%$ 48.974 millions
Travere Therapeutics Inc 48.17%$ 48.174 millions
Halozyme Therapeutics Inc 47.67%$ 47.673 millions
Eli Lilly And Company47.67%$ 47.670 millions
Rhythm Pharmaceuticals Inc 46.91%$ 46.911 millions
Axsome Therapeutics Inc 45.54%$ 45.543 millions
Guardant Health Inc 44.33%$ 44.332 millions
Omada Health Inc 43.27%$ 43.273 millions


About Beta Bionics Inc Revenue Growth Rates (BBNX), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Beta Bionics Inc (CIK 1674632).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-323777
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Beta Bionics Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.